Tonix Pharmaceuticals Holding (TNXP) Gross Margin (2023 - 2026)
Tonix Pharmaceuticals Holding's Gross Margin came in at 94.81% for Q2 2026, up 158.57 percentage points from -63.76% a year earlier and up 17.75 percentage points from the prior quarter.
Tonix Pharmaceuticals Holding (TNXP) Gross Margin (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Tonix Pharmaceuticals Holding reported Gross Margin of 83.83%, up 54.55 percentage points year-over-year; for FY2025, it came in at 49.34%, up 26.27 percentage points from FY2024.
- Going back by year, Gross Margin was 23.07% in FY2024 (-15.89 pp) and 38.97% in FY2023.
- The Q2 2026 figure represents the highest quarterly Gross Margin in data going back to Q3 2023.
- Year-over-year, Gross Margin has increased for four consecutive quarters, with an average year-over-year change of +31.53 percentage points over the last eight quarters.
- The fastest year-over-year change in Gross Margin over five years came in Q2 2026 (a gain of 158.57 percentage points), and the weakest in Q2 2025 (a drop of 11.27 percentage points).
- Business Quant data shows TNXP's Gross Margin at 77.06% (Q1 2026), 80.37% (Q4 2025) and 58.45% (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Tonix Pharmaceuticals Holding | 166.24 Mn | 166.24 Mn | 12.84 Mn | 94.81% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 94.81% |
| Mar 31, 2026 | 77.06% |
| Dec 31, 2025 | 80.37% |
| Sep 30, 2025 | 58.45% |
| Jun 30, 2025 | -63.76% |
| Mar 31, 2025 | 61.18% |
| Dec 31, 2024 | 54.18% |
| Sep 30, 2024 | 44.90% |
| Jun 30, 2024 | -52.49% |
| Mar 31, 2024 | 33.12% |
| Dec 31, 2023 | 37.36% |
| Sep 30, 2023 | 40.49% |
Tonix Pharmaceuticals Holding Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=TNXP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "TNXP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=TNXP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();